While Crown is the world’s leading supplier of oncology services, with a global footprint spanning three major continents in North America, Europe and Asia Pacific, Japan is seen as a market with ...
“The productivity and speed of stable cell line generation with the SUREtechnology Platform™ is playing a key role in quickly progressing our candidate into clinical development,” said Dr. Megan Ba...
With this joint effort, the Center will dramatically expand the combined operational capacity to support global translational oncology efforts, particularly mouse clinical trial (HuTrialTM platform...
With an established track record in providing expert support to direct cancer drug development projects from concept to clinic, the acquisition of PRECOS bolsters Crown Bioscience’s services global...
By combining their drug discovery and translational research platforms, Crown Bioscience and Horizon Discovery will help their customers select and advance the highest quality drug candidates to cl...
High-quality human disease models are crucial for generating ‘first-in-class’ patient-relevant targets and facilitating the development of novel oncology targets and early-stage drug discovery prog...
22 of 23
Receive JSR Life Sciences news on your RSS reader.
